Rachel E Simpson
Overview
Explore the profile of Rachel E Simpson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
148
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Simpson R, Ceppa E, Wu H, Akisik F, House M, Zyromski N, et al.
J Gastrointest Surg
. 2019 Jan;
23(8):1593-1603.
PMID: 30603862
Objective(s): A dilated main pancreatic duct in the distal remnant after proximal pancreatectomy for intraductal papillary mucinous neoplasms (IPMN) poses a diagnostic dilemma. We sought to determine parameters predictive of...
12.
Simpson R, Wang C, House M, Zyromski N, Schmidt C, Nakeeb A, et al.
HPB (Oxford)
. 2019 Jan;
21(7):818-826.
PMID: 30595461
Background: Centralization of complex surgical care leads to increased travel distances for patients. We sought to determine if increased travel distance to the index hospital altered inpatient Visit rates following...
13.
Simpson R, Yip-Schneider M, Wu H, Fan H, Liu Z, Korc M, et al.
Am J Surg
. 2018 Oct;
217(3):425-428.
PMID: 30293901
Background: IPMNs are cystic pancreatic lesions with variable malignant potential. Thrombospondin-2 (THBS2)-an endogenous, anti-angiogenic matrix glycoprotein-may modulate tumor progression. We hypothesized that circulating levels of THBS2 could aid in preoperative...
14.
Simpson R, Cockerill N, Yip-Schneider M, Ceppa E, House M, Zyromski N, et al.
HPB (Oxford)
. 2018 Oct;
21(5):574-581.
PMID: 30293868
Background: For pancreatic cysts with negative cytology, Integrated Molecular Pathology (IMP) is a malignancy risk score integrating clinical criteria with pancreatic cyst fluid DNA profiling. Aside from main pancreatic duct...
15.
Simpson R, Cockerill N, Yip-Schneider M, Ceppa E, House M, Zyromski N, et al.
Surgery
. 2018 Aug;
164(4):712-718.
PMID: 30139561
Background: Predicting malignancy in intraductal papillary mucinous neoplasm remains challenging. Integrated molecular pathology combines pancreatic fluid DNA and clinical factors into a malignant potential score. We sought to determine the...
16.
Carr R, Yip-Schneider M, Simpson R, Dolejs S, Schneider J, Wu H, et al.
Surgery
. 2017 Dec;
163(3):600-605.
PMID: 29241991
Background: The most widely accepted biochemical test for preoperative differentiation of mucinous from benign, nonmucinous pancreatic cysts is cyst fluid carcinoembryonic antigen. However, the diagnostic accuracy of carcinoembryonic antigen ranges...
17.
Simpson R, Ciruela A, Cooper D
J Biol Chem
. 2006 Apr;
281(25):17379-17389.
PMID: 16613843
Ca2+ stimulation of adenylyl cyclase type 8 (AC8) is mediated by calmodulin (CaM). An earlier study identified two CaM binding sites in AC8; one that was apparently not essential for...